What You Should Know: Welldoc®, a digital health leader revolutionizing chronic care, today announced the receipt of its 11th 510(k) clearance from the Food and Drug Administration (FDA) for its award-winning diabetes digital health solution, BlueStar®.This clearance immediately follows Welldoc’s 10th 510K clearance announcement earlier this month, solidifying the company’s continued leadership in chronic care innovation. A Continuous Glucose Monitoring (CGM) Informed Bolus Insulin Dose
Read More
Diabetes Management Platform | Type 1 & 2 Diabetes Patients | News, Analysis, Insights - HIT Consultant
Rimidi Enhances Integration with Dexcom, Adds Glycemic Risk Index to Diabetes Platform
What You Should Know: Rimidi, a clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, is announcing enhancements to its diabetes management platform, including the addition of Glycemic Risk Index (GRI) as an emerging tool for patient and population outcomes management. The inclusion of CGM data and GRI into Rimidi’s platform and clinical workflows is made possible via an enhanced integration with Dexcom, a
Read More
Rimidi and ARKRAY Partner to Bring Glucose Data to the EHR
What You Should Know: - In an effort to make blood glucose data more actionable for providers and patients alike, Rimidi, a leading clinical management platform announced its integration with the ARKRAY GLUCOCARD® Shine Connex Blood Glucose Monitoring System to Rimidi’s Platform. - The integration enables providers to manage blood-glucose control more proactively within existing workflows, thus boosting patient adherence. Blood Glucose Data Directly Embedded in EHR Diabetes is the
Read More
9am.health, Ascensia Partner to Expand Virtual Diabetes Clinic
What You Should Know: - 9am.health today announced it is expanding its virtual diabetes clinic through a strategic partnership with Ascensia to add the CONTOUR®NEXT ONE Blood Glucose Meter to Its patient toolkit. - 9am.health patients can now conveniently add Ascensia Diabetes Care’s blood glucose meter and test strips to their personalized treatment plan, with the meter offered free of charge to all patient care plans. The test strip add-on is available through a
Read More
Glooko Raises $30M to Expand Digital Diabetes Management Platform
What You Should Know: - Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. - Glooko plans to use these proceeds from this funding to accelerate organic growth and
Read More
4 Predictions for Diabetes Management and Technology in 2021
The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of technology to address dire patient needs. Health systems, physicians, and frontline staff pulled together in remarkable fashion to implement these emerging technologies that enhance the ways patients
Read More
Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population
What You Should Know: - Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. - Vida’s diabetes management program achieves lasting results for participants. Because chronic conditions like diabetes, obesity, and hypertension often occur simultaneously, Vida’s unique program was built from the ground up to treat multiple conditions at the same time. - The new partnership, which will
Read More
Virta Adds Prediabetes and Obesity Reversal to Services
What You Should Know: - Virta is expanding its suite of treatment options to include prediabetes reversal, obesity reversal, and type 2 diabetes management. - By making this crucial expansion, Virta can scale its treatment to support the tens of millions of additional patients with prediabetes and obesity, as provide an on-ramp to reversal for those with T2D that aren’t yet ready to reverse. Virta Health, the leader in type 2 diabetes reversal, today introduced the addition
Read More
Medtronic Acquires Smart Insulin Pen Company Companion Medical
What You Should Know: - Today, Medtronic announced that it will acquire Companion Medical, the manufacturer of InPen, a smart insulin pen system paired with an integrated diabetes management app. - The addition of Companion’s InPen system builds upon Medtronic's strategic acquisitions of Nutrino and Klue to further improve overall automated decision-making capabilities and optimizes dosing decisions using algorithms and AI for patients. Medtronic, today announced the
Read More
DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care
What You Should Know: - DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust. - DreaMed uses AI-powered technology to seamlessly treat patients remotely with its virtual diabetes management service by
Read More
